-
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma
G. Gandolfi, M. Ragazzi, A. Frasoldati, S. Piana, A. Ciarrocchi, and V. Sancisi
European Journal of Endocrinology
(2015)
172 :403
-
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities
Christian Koelsche, Marcus Renner, Wolfgang Hartmann, Regine Brandt, Burkhard Lehner, Nina Waldburger, Ingo Alldinger, Thomas
Schmitt, Gerlinde Egerer, Roland Penzel, Eva Wardelmann, Peter Schirmacher, Andreas von Deimling, and Gunhild Mechtersheimer
Journal of Experimental & Clinical Cancer Research
(2014)
33 :33
-
BRAF
V600E
mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from
Chernobyl
Norisato Mitsutake, Toshihiko Fukushima, Michiko Matsuse, Tatiana Rogounovitch, Vladimir Saenko, Shinya Uchino, Masahiro Ito,
Keiji Suzuki, Shinichi Suzuki, and Shunichi Yamashita
Scientific Reports
(2015)
5 :
-
Prognostic effects ofTERTpromoter mutations are enhanced by coexistence withBRAForRASmutations and strengthen the risk prediction
by the ATA or TNM staging system in differentiated thyroid cancer patients
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee
Yi, Do Joon Park, and Jeong-Sun Seo
Cancer
(2016)
122 :1370
-
Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma
Minghua Ge, Meng Shi, Changming An, Wenjun Yang, Xilin Nie, Jian Zhang, Zheng Lv, Jinliang Li, Liqing Zhou, Zhongli Du, and
Ming Yang
Scientific Reports
(2016)
6 :
-
The Cancer Genomics Resource List 2014
Mary M. Zutter, Kenneth J. Bloom, Liang Cheng, Ian S. Hagemann, Jill H. Kaufman, Alyssa M. Krasinskas, Alexander J. Lazar,
Debra G. B. Leonard, Neal I. Lindeman, Ann M. Moyer, Marina N. Nikiforova, Jan A. Nowak, John D. Pfeifer, Antonia R. Sepulveda,
Joseph E. Willis, and Sophia L. Yohe
Archives of Pathology & Laboratory Medicine
(2015)
139 :989
-
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
João Vinagre, Vasco Pinto, Ricardo Celestino, Marta Reis, Helena Pópulo, Paula Boaventura, Miguel Melo, Telmo Catarino, Jorge
Lima, José Manuel Lopes, Valdemar Máximo, Manuel Sobrinho-Simões, and Paula Soares
Virchows Archiv
(2014)
465 :119
-
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
T. Liu, T. C. Brown, C. C. Juhlin, A. Andreasson, N. Wang, M. Backdahl, J. M. Healy, M. L. Prasad, R. Korah, T. Carling, D.
Xu, and C. Larsson
Endocrine Related Cancer
(2014)
21 :427
-
Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer
Seo Young Sohn, Woong Yang Park, Hyun Tae Shin, Joon Seol Bae, Chang Seok Ki, Young Lyun Oh, Sun Wook Kim, and Jae Hoon Chung
Thyroid
(2016)
26 :672
-
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid
Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, Gerard M. Doherty, Susan J. Mandel, Yuri E. Nikiforov, Furio Pacini, Gregory
W. Randolph, Anna M. Sawka, Martin Schlumberger, Kathryn G. Schuff, Steven I. Sherman, Julie Ann Sosa, David L. Steward, R.
Michael Tuttle, and Leonard Wartofsky
Thyroid
(2016)
26 :1
-
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives
Emma Scott, Diana Learoyd, and Roderick J Clifton-Bligh
Future Oncology
(2016)
12 :2603
-
Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in aBRAFV600EMutation-Prevalent
Area
Min Ji Jeon, Sung-Min Chun, Deokhoon Kim, Hyemi Kwon, Eun Kyung Jang, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Se Jin Jang,
Dong Eun Song, and Won Gu Kim
Thyroid
(2016)
26 :683
-
Molecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a “Tibetan Mastiff Dog” From
Puppies
Dapeng Li, Ming Gao, Xiaolong Li, and Mingzhao Xing
Journal of Cellular Biochemistry
(2016)
117 :1491
-
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
Cesar Seigi Fuziwara and Edna Teruko Kimura
International Journal of Endocrinology
(2014)
2014 :1
-
The Role of Genetic Markers in the Evaluation and Management of Thyroid Nodules
Sareh Parangi and Hyunsuk Suh
Surgical Clinics of North America
(2014)
94 :515
-
Thyroglobulin in Metastatic Thyroid Cancer: Culprit or Red Herring?
Lamis Yehia, Ying Ni, and Charis Eng
The American Journal of Human Genetics
(2017)
100 :562
-
Single Point Mutations in Pediatric Differentiated Thyroid Cancer
Ali S. Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, Meshael Alswailem, Hindi Al-Hindi, and Yufei Shi
Thyroid
(2017)
27 :189
-
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK
and NF1 mutations in anaplastic thyroid cancer
Soeren Latteyer, Vera Tiedje, Katharina König, Saskia Ting, Lukas C. Heukamp, Lydia Meder, Kurt Werner Schmid, Dagmar Führer,
and Lars Christian Moeller
Endocrine
(2016)
54 :733
-
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia
T. G. Papathomas, L. Oudijk, E. C. Zwarthoff, E. Post, F. A. Duijkers, M. M. van Noesel, L. J. Hofland, P. J. Pollard, E.
R. Maher, D. F. Restuccia, R. A. Feelders, G. J. H. Franssen, H. J. Timmers, S. Sleijfer, W. W. de Herder, R. R. de Krijger,
W. N. M. Dinjens, and E. Korpershoek
Endocrine Related Cancer
(2014)
21 :653
-
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two
independent factors
Michiko Matsuse, Tomonori Yabuta, Vladimir Saenko, Mitsuyoshi Hirokawa, Eijun Nishihara, Keiji Suzuki, Shunichi Yamashita,
Akira Miyauchi, and Norisato Mitsutake
Scientific Reports
(2017)
7 :41752
-
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Moira Ragazzi, Alessia Ciarrocchi, Valentina Sancisi, Greta Gandolfi, Alessandra Bisagni, and Simonetta Piana
International Journal of Endocrinology
(2014)
2014 :1
-
TERT Promoter Mutations in Thyroid Cancer
Ali S. Alzahrani, Rawan Alsaadi, Avaniyapuram Kannan Murugan, and Bakr Bin Sadiq
Hormones and Cancer
(2016)
7 :165
-
The current role of targeted therapies to induce radioiodine uptake in thyroid cancer
Eleonore Fröhlich and Richard Wahl
Cancer Treatment Reviews
(2014)
40 :665
-
Sorafenib in the treatment of thyroid cancer
Silvia Martina Ferrari, Ugo Politti, Roberto Spisni, Gabriele Materazzi, Enke Baldini, Salvatore Ulisse, Paolo Miccoli, Alessandro
Antonelli, and Poupak Fallahi
Expert Review of Anticancer Therapy
(2015)
15 :863
-
Genomic complexity and targeted genes in anaplastic thyroid cancer cell lines
Eleanor L Woodward, Andrea Biloglav, Naveen Ravi, Minjun Yang, Lars Ekblad, Johan Wennerberg, and Kajsa Paulsson
Endocrine-Related Cancer
(2017)
24 :209
-
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
Miguel Melo, Adriana Gaspar da Rocha, Rui Batista, João Vinagre, Maria João Martins, Gracinda Costa, Cristina Ribeiro, Francisco
Carrilho, Valeriano Leite, Cláudia Lobo, José Manuel Cameselle-Teijeiro, Bruno Cavadas, Luísa Pereira, Manuel Sobrinho-Simões,
and Paula Soares
The Journal of Clinical Endocrinology & Metabolism
(2017)
102 :1898
-
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Dagmara Rusinek, Ewa Chmielik, Jolanta Krajewska, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Agnieszka Czarniecka, and
Barbara Jarzab
International Journal of Molecular Sciences
(2017)
18 :1817
-
Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations
and insignificant role of BRAF mutations—a meta-analysis
Huy Gia Vuong, Ahmed MA Altibi, Uyen NP Duong, Hanh TT Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki,
Tadao Nakazawa, Lewis Hassell, Ryohei Katoh, and Tetsuo Kondo
Tumor Biology
(2017)
39 :101042831771391
-
Current Status and Future Perspectives in Differentiated Thyroid Cancer
Tae Yong Kim, Won Gu Kim, Won Bae Kim, and Young Kee Shong
Endocrinology and Metabolism
(2014)
29 :217
-
ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome
Garcilaso Riesco-Eizaguirre and Pilar Santisteban
European Journal of Endocrinology
(2016)
175 :R203
-
Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis?
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Manuel Sobrinho-Simões, and Paula Soares
Journal of Clinical Oncology
(2015)
33 :667
-
TERT Promoter Mutations Occur in Aggressive Thyroid Cancers That Often Contain the BRAF Mutation
Jerome M. Hershman
Clinical Thyroidology
(2014)
26 :134
-
External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck
Society
Ana P. Kiess, Nishant Agrawal, James D. Brierley, Umamaheswar Duvvuri, Robert L. Ferris, Eric Genden, Richard J. Wong, R.
Michael Tuttle, Nancy Y. Lee, and Gregory W. Randolph
Head & Neck
(2016)
38 :493
-
ZCCHC12, a novel oncogene in papillary thyroid cancer
Ouchen Wang, Zhouci Zheng, Qingxuan Wang, Yixiang Jin, Wenxu Jin, Yinghao Wang, Endong Chen, and Xiaohua Zhang
Journal of Cancer Research and Clinical Oncology
(2017)
143 :1679
-
The prognostic impact of TERT
promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
Rui Batista, Adriana Cruvinel-Carloni, João Vinagre, Joana Peixoto, Telmo A. Catarino, Nathalia Cristina Campanella, Weder
Menezes, Aline Paixão Becker, Gisele Caravina de Almeida, Marcus M. Matsushita, Carlos Clara, Luciano Neder, Marta Viana-Pereira,
Mrinalini Honavar, Lígia Castro, José Manuel Lopes, Bruno Carvalho, Rui Manuel Vaz, Valdemar Máximo, Paula Soares, Manuel
Sobrinho-Simões, Rui Manuel Reis, and Jorge Lima
International Journal of Cancer
(2016)
139 :414
-
The Prognostic Implications from Molecular Testing of Thyroid Cancer
Ozan B. Ozgursoy, David W. Eisele, and Ralph P. Tufano
Otolaryngologic Clinics of North America
(2014)
47 :595
-
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features
of aggressiveness
Elisabetta Macerola, Barbara Loggini, Riccardo Giannini, Giulia Garavello, Mirella Giordano, Agnese Proietti, Cristina Niccoli,
Fulvio Basolo, and Gabriella Fontanini
Virchows Archiv
(2015)
467 :177
-
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
Nils J Fredriksson, Lars Ny, Jonas A Nilsson, and Erik Larsson
Nature Genetics
(2014)
46 :1258
-
Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy
R. Liu and M. Xing
Endocrine Related Cancer
(2014)
21 :825
-
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
Catarina Tavares, Miguel Melo, José Manuel Cameselle-Teijeiro, Paula Soares, and Manuel Sobrinho-Simões
European Journal of Endocrinology
(2016)
174 :R117
-
In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast
to BRAF V600E mutation
Almira Nasirden, Tsuyoshi Saito, Yuki Fukumura, Kieko Hara, Keisuke Akaike, Aiko Kurisaki-Arakawa, Miki Asahina, Atsushi Yamashita,
Ran Tomomasa, Takuo Hayashi, Atsushi Arakawa, and Takashi Yao
Virchows Archiv
(2016)
469 :687
-
Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT
M. S Dettmer, A. Schmitt, H. Steinert, D. Capper, H. Moch, P. Komminoth, and A. Perren
Endocrine Related Cancer
(2015)
22 :419
-
The management of thyroid nodules and cancer in the molecular era
Ling Zhou and Kepal N Patel
International Journal of Endocrine Oncology
(2015)
2 :301
-
Inhibition of Telomerase Recruitment and Cancer Cell Death
Mai Nakashima, Jayakrishnan Nandakumar, Kelly D. Sullivan, Joaquín M. Espinosa, and Thomas R. Cech
Journal of Biological Chemistry
(2013)
288 :33171
-
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A. Zeiger, Sara Pai, and Justin Bishop
Journal of Clinical Oncology
(2014)
32 :2718
-
Reconstruction of enhancer–target networks in 935 samples of human primary cells, tissues and cell lines
Qin Cao, Christine Anyansi, Xihao Hu, Liangliang Xu, Lei Xiong, Wenshu Tang, Myth T S Mok, Chao Cheng, Xiaodan Fan, Mark Gerstein,
Alfred S L Cheng, and Kevin Y Yip
Nature Genetics
(2017)
49 :1428
-
Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters
Jaroslaw Jendrzejewski, Sandya Liyanarachchi, Rebecca Nagy, Leigha Senter, Paul E. Wakely, Andrew Thomas, Fadi Nabhan, Huiling
He, Wei Li, Krzysztof Sworczak, Matthew D. Ringel, Lawrence S. Kirschner, and Albert de la Chapelle
Thyroid
(2016)
26 :1276
-
Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer
Daham Kim, Woo Kyung Lee, Seonhyang Jeong, Mi-Youn Seol, Hyunji Kim, Kyung-Sup Kim, Eun Jig Lee, Jandee Lee, and Young Suk
Jo
Molecular and Cellular Endocrinology
(2016)
431 :36
-
Telomerase: The Devil Inside
Mukesh Kumar, Andre Lechel, and Çagatay Güneş
Genes
(2016)
7 :43
-
Reactivation of telomerase in cancer
Semih Can Akincilar, Bilal Unal, and Vinay Tergaonkar
Cellular and Molecular Life Sciences
(2016)
73 :1659
-
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors
Marina N. Nikiforova, Abigail I. Wald, Melissa A. Melan, Somak Roy, Shan Zhong, Ronald L. Hamilton, Frank S. Lieberman, Jan
Drappatz, Nduka M. Amankulor, Ian F. Pollack, Yuri E. Nikiforov, and Craig Horbinski
Neuro-Oncology
(2016)
18 :379
-
Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms
A. Proietti, C. Sartori, E. Macerola, N. Borrelli, G. Materazzi, P. Vitti, and F. Basolo
Virchows Archiv
(2017)
:
-
TERTpromoter mutation is uncommon in acral lentiginous melanoma
Jau-Yu Liau, Jia-Huei Tsai, Yung-Ming Jeng, Chia-Yu Chu, Kuan-Ting Kuo, and Cher-Wei Liang
Journal of Cutaneous Pathology
(2014)
41 :504
-
Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review]
Yasuhiro Ito, Hitomi Oda, and Akira Miyauchi
Endocrine Journal
(2016)
63 :323
-
TERT and BRAF in Thyroid Cancer: Teaming Up for Trouble
Joanne Ngeow and Charis Eng
Journal of Clinical Oncology
(2014)
32 :2683
-
Rolle der Molekularpathologie beim Schilddrüsenkarzinom
K.W. Schmid and D. Führer
Der Onkologe
(2015)
21 :584
-
TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A
Meta-analysis
Chunping Liu, Zeming Liu, Tianwen Chen, Wen Zeng, Yawen Guo, and Tao Huang
Scientific Reports
(2016)
6 :
-
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma
Bin Xu and Ronald Ghossein
Endocrine Pathology
(2016)
27 :205
-
Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer
Thanyawat Sasanakietkul, Timothy D. Murtha, Mahsa Javid, Reju Korah, and Tobias Carling
Molecular and Cellular Endocrinology
(2017)
:
-
TERT promoter mutations in cancer development
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Kari Hemminki, and Rajiv Kumar
Current Opinion in Genetics & Development
(2014)
24 :30
-
Characterization of Thyroid Cancer Cell Lines in Murine Orthotopic and Intracardiac Metastasis Models
Jennifer A. Morrison, Laura A. Pike, Greg Lund, Qiong Zhou, Brittelle E. Kessler, Kevin T. Bauerle, Sharon B. Sams, Bryan
R. Haugen, and Rebecca E. Schweppe
Hormones and Cancer
(2015)
6 :87
-
Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the
BRAF V600E mutation
Ja Seong Bae, Yourha Kim, Sora Jeon, Se Hee Kim, Tae Jung Kim, Sohee Lee, Min-Hee Kim, Dong Jun Lim, Youn Soo Lee, and Chan
Kwon Jung
Diagnostic Pathology
(2016)
11 :
-
Low frequency ofTERTpromoter mutations in a large cohort of gallbladder and gastric cancers
Yiping Qu, Lei Shi, Dan Wang, Bingfei Zhang, Qi Yang, Meiju Ji, Bingyin Shi, and Peng Hou
International Journal of Cancer
(2014)
134 :2993
-
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology
by ThyroSeq v2 next-generation sequencing assay
Yuri E. Nikiforov, Sally E. Carty, Simon I. Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L. Ferris, William E.
Gooding, Steven P. Hodak, Shane O. LeBeau, N. Paul Ohori, Raja R. Seethala, Mitchell E. Tublin, Linwah Yip, and Marina N.
Nikiforova
Cancer
(2014)
120 :3627
-
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke, Vijay Ramaswamy, John Peacock, David J. H. Shih, Christian Koelsche, Paul A. Northcott, Nadia Hill, Florence M.
G. Cavalli, Marcel Kool, Xin Wang, Stephen C. Mack, Mark Barszczyk, A. Sorana Morrissy, Xiaochong Wu, Sameer Agnihotri, Betty
Luu, David T. W. Jones, Livia Garzia, Adrian M. Dubuc, Nataliya Zhukova, Robert Vanner, Johan M. Kros, Pim J. French, Erwin
G. Van Meir, Rajeev Vibhakar, Karel Zitterbart, Jennifer A. Chan, László Bognár, Almos Klekner, Boleslaw Lach, Shin Jung,
Ali G. Saad, Linda M. Liau, Steffen Albrecht, Massimo Zollo, Michael K. Cooper, Reid C. Thompson, Oliver O. Delattre, Franck
Bourdeaut, François F. Doz, Miklós Garami, Peter Hauser, Carlos G. Carlotti, Timothy E. Van Meter, Luca Massimi, Daniel Fults,
Scott L. Pomeroy, Toshiro Kumabe, Young Shin Ra, Jeffrey R. Leonard, Samer K. Elbabaa, Jaume Mora, Joshua B. Rubin, Yoon-Jae
Cho, Roger E. McLendon, Darell D. Bigner, Charles G. Eberhart, Maryam Fouladi, Robert J. Wechsler-Reya, Claudia C. Faria,
Sidney E. Croul, Annie Huang, Eric Bouffet, Cynthia E. Hawkins, Peter B. Dirks, William A. Weiss, Ulrich Schüller, Ian F.
Pollack, Stefan Rutkowski, David Meyronet, Anne Jouvet, Michelle Fèvre-Montange, Nada Jabado, Marta Perek-Polnik, Wieslawa
A. Grajkowska, Seung-Ki Kim, James T. Rutka, David Malkin, Uri Tabori, Stefan M. Pfister, Andrey Korshunov, Andreas von Deimling,
and Michael D. Taylor
Acta Neuropathologica
(2013)
126 :917
-
TERTpromoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis
irradiation
Paula Boaventura, Rui Batista, Ana Pestana, Marta Reis, Adélia Mendes, Catarina Eloy, Manuel Sobrinho-Simões, and Paula Soares
European Journal of Endocrinology
(2017)
176 :49
-
Low Prevalence of SomaticTERTPromoter Mutations in Classic Papillary Thyroid Carcinoma
Min Ji Jeon, Won Gu Kim, Soyoung Sim, Seonhee Lim, Hyemi Kwon, Tae Yong Kim, Young Kee Shong, and Won Bae Kim
Endocrinology and Metabolism
(2016)
31 :100
-
TERTpromoter mutations and long-term survival in patients with thyroid cancer
Tae Hyuk Kim, Young-Eun Kim, Soomin Ahn, Ji-Youn Kim, Chang-Seok Ki, Young Lyun Oh, Kyunga Kim, Jae Won Yun, Woong-Yang Park,
Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Sun Wook Kim, and Jae Hoon Chung
Endocrine-Related Cancer
(2016)
23 :813
-
Multiple Mutations Detected Preoperatively May Predict Aggressive Behavior of Papillary Thyroid Cancer and Guide Management—A
Case Report
Rupendra T. Shrestha, Arivarasan Karunamurthy, Khalid Amin, Yuri E. Nikiforov, and M. Luiza Caramori
Thyroid
(2015)
25 :1375
-
When Thyroid Carcinoma Goes Bad: A Morphological and Molecular Analysis
Sylvia Papp and Sylvia L. Asa
Head and Neck Pathology
(2015)
9 :16
-
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T. W. Jones, Marcel Kool, Paul A. Northcott,
Benedikt Wiestler, Katja Böhmer, Jochen Meyer, Christian Mawrin, Christian Hartmann, Michel Mittelbronn, Michael Platten,
Benjamin Brokinkel, Marcel Seiz, Christel Herold-Mende, Andreas Unterberg, Jens Schittenhelm, Michael Weller, Stefan Pfister,
Wolfgang Wick, Andrey Korshunov, and Andreas von Deimling
Acta Neuropathologica
(2013)
126 :907
-
BRAF and Epithelial-Mesenchymal Transition
Brendon Mitchell, Jagdish K. Dhingra, and Meera Mahalingam
Advances In Anatomic Pathology
(2016)
23 :244
-
Enhancer alterations in cancer: a source for a cell identity crisis
Ken J Kron, Swneke D Bailey, and Mathieu Lupien
Genome Medicine
(2014)
6 :
-
Frequent BRAF
V600E
and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan
Naoki Oishi, Tetsuo Kondo, Tadao Nakazawa, Kunio Mochizuki, Tomohiro Inoue, Kazunari Kasai, Ippei Tahara, Tomonori Yabuta,
Mitsuyoshi Hirokawa, Akira Miyauchi, and Ryohei Katoh
Endocrine Pathology
(2017)
28 :103
-
BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
Jian Sun, Jing Zhang, Junliang Lu, Jie Gao, Xinyu Ren, Lianghong Teng, Huanli Duan, Yansong Lin, Xiaoyi Li, Bo Zhang, Zhiyong
Liang, and Yan W. Asmann
PLOS ONE
(2016)
11 :e0153319
-
The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, and D Xu
Oncogene
(2014)
33 :4978
-
Follicular cell-derived thyroid cancer
Henning Dralle, Andreas Machens, Johanna Basa, Vahab Fatourechi, Silvia Franceschi, Ian D. Hay, Yuri E. Nikiforov, Furio Pacini,
Janice L. Pasieka, and Steven I. Sherman
Nature Reviews Disease Primers
(2015)
:15077
-
Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity
Jeffrey F. Krane, Edmund S. Cibas, Erik K. Alexander, Ralf Paschke, and Markus Eszlinger
Cancer Cytopathology
(2015)
123 :356
-
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Tiantian Liu, Xiaotian Yuan, and Dawei Xu
Genes
(2016)
7 :38
-
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer
Mingzhao Xing
BMC Medicine
(2016)
14 :
-
Recurrent TERT promoter mutations in non-small cell lung cancers
Xiao Ma, Ranxia Gong, Rui Wang, Yunjian Pan, Deng Cai, Bin Pan, Yuan Li, Jiaqing Xiang, Hecheng Li, Jie Zhang, Yihua Sun,
and Haiquan Chen
Lung Cancer
(2014)
86 :369
-
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Muhammad Ramlee, Jing Wang, Wei Toh, and Shang Li
Genes
(2016)
7 :50
-
TERTPromoter Mutations in Papillary Thyroid Microcarcinomas
Dario de Biase, Greta Gandolfi, Moira Ragazzi, Markus Eszlinger, Valentina Sancisi, Mila Gugnoni, Michela Visani, Annalisa
Pession, Gianpaolo Casadei, Cosimo Durante, Giuseppe Costante, Rocco Bruno, Massimo Torlontano, Ralf Paschke, Sebastiano Filetti,
Simonetta Piana, Andrea Frasoldati, Giovanni Tallini, and Alessia Ciarrocchi
Thyroid
(2015)
25 :1013
-
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation
as an independent risk factor for transformation
Naoki Oishi, Tetsuo Kondo, Aya Ebina, Yukiko Sato, Junko Akaishi, Rumi Hino, Noriko Yamamoto, Kunio Mochizuki, Tadao Nakazawa,
Hiroshi Yokomichi, Koichi Ito, Yuichi Ishikawa, and Ryohei Katoh
Modern Pathology
(2017)
:
-
Application of molecular biology of differentiated thyroid cancer for clinical prognostication
Vincenzo Marotta, Concetta Sciammarella, Annamaria Colao, and Antongiulio Faggiano
Endocrine-Related Cancer
(2016)
23 :R485
-
GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
Jandee Lee, Seonhyang Jeong, Cho Rok Lee, Cheol Ryong Ku, Sang-Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Dong Yeob Shin, Woong
Youn Chung, Eun Jig Lee, and Young Suk Jo
Medicine
(2015)
94 :e998
-
Les cancers de la thyroïde : de l’épidémiologie à la biologie moléculaire
F. Lalmi, J.-L. Sadoul, and V. Rohmer
Annales d'Endocrinologie
(2015)
76 :S19
-
Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy
Linwah Yip
Journal of Surgical Oncology
(2015)
111 :43
-
Tumor Genotype Determines Phenotype and Disease-related Outcomes in Thyroid Cancer
Linwah Yip, Marina N. Nikiforova, Jenny Y. Yoo, Kelly L. McCoy, Michael T. Stang, Michaele J. Armstrong, Kristina J. Nicholson,
N. Paul Ohori, Christopher Coyne, Steven P. Hodak, Robert L. Ferris, Shane O. LeBeau, Yuri E. Nikiforov, and Sally E. Carty
Annals of Surgery
(2015)
262 :519
-
Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations
Tae Hyuk Kim, Chang-Seok Ki, Hye Seung Kim, Kyunga Kim, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Young Lyun Oh, Soo Yeon Hahn,
Jung Hee Shin, Hye Won Jang, Sun Wook Kim, and Jae Hoon Chung
The Journal of Clinical Endocrinology & Metabolism
(2017)
102 :1757
-
The Combination of TERT and BRAF Mutations Identify PTCs with High Recurrence
Jerome M. Hershman
Clinical Thyroidology
(2014)
26 :247
-
Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric
Case Series at a Tertiary-Level Endocrinology Unit
Simona Censi, Elisabetta Cavedon, Loris Bertazza, Francesca Galuppini, Sara Watutantrige-Fernando, Paola De Lazzari, Davide
Nacamulli, Gianmaria Pennelli, Ambrogio Fassina, Maurizio Iacobone, Eric Casal Ide, Federica Vianello, Susi Barollo, and Caterina
Mian
Frontiers in Endocrinology
(2017)
8 :
-
Identification of somatic TERT
promoter mutations in familial nonmedullary thyroid carcinomas
Inês J. Marques, Margarida M. Moura, Rafael Cabrera, António E. Pinto, Joana Simões-Pereira, Catarina Santos, Francisco D.
Menezes, Diana Montezuma, Rui Henrique, Manuel Rodrigues Teixeira, Valeriano Leite, and Branca M. Cavaco
Clinical Endocrinology
(2017)
87 :394
-
Reply to M. Melo et al
Mingzhao Xing
Journal of Clinical Oncology
(2015)
33 :668
-
TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas
Vilvanathan Vinothkumar, Ganesan Arunkumar, Sundaramoorthy Revathidevi, Kanagaraj Arun, Mayakannan Manikandan, Arunagiri Kuha
Deva Magendhra Rao, Kottayasamy Seenivasagam Rajkumar, Chandrasekar Ajay, Ramamurthy Rajaraman, Rajendren Ramani, Avaniyapuram
Kannan Murugan, and Arasambattu Kannan Munirajan
Tumor Biology
(2016)
37 :7907
-
Aggressive variants of follicular cell-derived thyroid carcinomas: A cytopathologist's perspective
Ricardo R. Lastra, Virginia A. LiVolsi, and Zubair W. Baloch
Cancer Cytopathology
(2014)
122 :484
-
A new appraisal of iodine refractory thyroid cancer
Fernanda Vaisman, Denise P Carvalho, and Mario Vaisman
Endocrine-Related Cancer
(2015)
22 :R301
-
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
Shinje Moon, Young Shin Song, Ye An Kim, Jung Ah Lim, Sun Wook Cho, Jae Hoon Moon, Seokyung Hahn, Do Joon Park, and Young
Joo Park
Thyroid
(2017)
27 :651
-
hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck
cancer
Wojciech Barczak, Wiktoria M. Suchorska, Agnieszka Sobecka, Karolina Bednarowicz, Piotr Machczynski, Pawel Golusinski, Blazej
Rubis, Michal M. Masternak, and Wojciech Golusinski
Molecular Medicine Reports
(2017)
16 :441
-
Altered TERT
promoter and other genomic regulatory elements: occurrence and impact
Barbara Heidenreich and Rajiv Kumar
International Journal of Cancer
(2017)
141 :867
-
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A. Knauf, Ronak H. Shah, Snjezana Dogan, Julio C. Ricarte-Filho,
Gnana P. Krishnamoorthy, Bin Xu, Nikolaus Schultz, Michael F. Berger, Chris Sander, Barry S. Taylor, Ronald Ghossein, Ian
Ganly, and James A. Fagin
Journal of Clinical Investigation
(2016)
126 :1052
-
Biologic and Clinical Perspectives on Thyroid Cancer
Dan L. Longo, James A. Fagin, and Samuel A. Wells
New England Journal of Medicine
(2016)
375 :1054
-
Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions
Leomar Y. Ballester, Stephen F. Sarabia, Hadi Sayeed, Nimesh Patel, Joshua Baalwa, Ioanna Athanassaki, Jose A. Hernandez,
Erica Fang, Norma M. Quintanilla, Angshumoy Roy, and Dolores H. López-Terrada
Pediatric and Developmental Pathology
(2016)
19 :94
-
Surgical considerations for papillary thyroid microcarcinomas
Laura Boucai, Victor Bernet, Ashok Shaha, Maisie L. Shindo, Brendan C. Stack, and Robert M. Tuttle
Journal of Surgical Oncology
(2017)
116 :269
-
Telomerase reverse transcriptase (TERT) promoter mutations in the tumors of human endocrine organs: Biological and prognostic
value
L. S. Selivanova, K. S. Volganova, and A. Yu. Abrosimov
Arkhiv patologii
(2016)
78 :62
-
ROLE OF MOLECULAR MARKERS IN THYROID NODULE MANAGEMENT: THEN AND NOW
Yuri E. Nikiforov
Endocrine Practice
(2017)
23 :979
-
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis
Huy Gia Vuong, Ahmed M.A. Altibi, Uyen N.P. Duong, and Lewis Hassell
Clinical Endocrinology
(2017)
:
-
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary
syndromes
João Vinagre, Joana Nabais, Jorge Pinheiro, Rui Batista, Rui Caetano Oliveira, António Pedro Gonçalves, Ana Pestana, Marta
Reis, Bárbara Mesquita, Vasco Pinto, Joana Lyra, Maria Augusta Cipriano, Miguel Godinho Ferreira, José Manuel Lopes, Manuel
Sobrinho-Simões, and Paula Soares
Scientific Reports
(2016)
6 :
-
Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing
(Review)
Brittany A. Avin, Christopher B. Umbricht, and Martha A. Zeiger
International Journal of Oncology
(2016)
49 :2199
-
TERTpromoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
Na Wang, Tiantian Liu, Anastasios Sofiadis, C. Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, and Dawei
Xu
Cancer
(2014)
120 :2965
-
Hobnail Variant of Papillary Thyroid Carcinoma
José M. Cameselle-Teijeiro, Irene Rodríguez-Pérez, Ricardo Celestino, Catarina Eloy, Magalí Piso-Neira, Ihab Abdulkader-Nallib,
Paula Soares, and Manuel Sobrinho-Simões
The American Journal of Surgical Pathology
(2017)
41 :854
-
Regulatory variation: an emerging vantage point for cancer biology
Luolan Li, Alireza Lorzadeh, and Martin Hirst
Wiley Interdisciplinary Reviews: Systems Biology and Medicine
(2014)
6 :37
-
UncommonTERTPromoter Mutations in Pediatric Thyroid Cancer
Ali S. Alzahrani, Ebtesam Qasem, Avaniyapuram Kannan Murugan, Hindi N. Al-Hindi, Dania AlKhafaji, Mai Almohanna, Mingzhao
Xing, Doha Alhomaidah, and Meshael AlSwailem
Thyroid
(2016)
26 :235
-
The story of poorly differentiated thyroid carcinoma: From Langhans’ description to the Turin proposal via Juan Rosai
Marco Volante, Gianni Bussolati, and Mauro Papotti
Seminars in Diagnostic Pathology
(2016)
33 :277
-
Detection of Malignancy Among Suspicious Thyroid Nodules <1 cm on Ultrasound with Various Thyroid Image Reporting and Data
Systems
Su Min Ha, Jae Kyun Kim, and Jung Hwan Baek
Thyroid
(2017)
27 :1307
-
TERT promoter mutations in telomere biology
Barbara Heidenreich and Rajiv Kumar
Mutation Research/Reviews in Mutation Research
(2017)
771 :15
-
<i>TERT</i> Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer
Jae Kyung Myung, Byung Kuk Kwak, Jung Ah Lim, Myung-Chul Lee, and Min Joo Kim
Cancer Research and Treatment
(2016)
48 :942
-
Prognostic Significance ofTERTPromoter Mutations in Papillary Thyroid Carcinomas in aBRAFV600EMutation–Prevalent Population
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, and Jung Hyun Yang
Thyroid
(2016)
26 :901
-
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR
Jinbo Liu, Zhihua Zhao, Miaomiao Sun, Kuisheng Chen, Weitang Yuan, and Guozhong Jiang
Genetic Testing and Molecular Biomarkers
(2016)
20 :90
-
TERTbiology and function in cancer: beyond immortalisation
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, and Paula Soares
Journal of Molecular Endocrinology
(2017)
58 :R129
-
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells
Valentina Maggisano, Marilena Celano, Giovanni Enrico Lombardo, Saverio Massimo Lepore, Marialuisa Sponziello, Francesca Rosignolo,
Antonella Verrienti, Federica Baldan, Efisio Puxeddu, Cosimo Durante, Sebastiano Filetti, Giuseppe Damante, Diego Russo, and
Stefania Bulotta
Molecular and Cellular Endocrinology
(2017)
448 :34
-
Key signaling pathways in thyroid cancer
Miguel A Zaballos and Pilar Santisteban
Journal of Endocrinology
(2017)
235 :R43
-
RASAL1 in Thyroid Cancer: Wisdom From an Old Foe
J. Ngeow and C. Eng
JNCI Journal of the National Cancer Institute
(2013)
105 :1597
-
Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization
Marina Muzza, Carla Colombo, Stefania Rossi, Delfina Tosi, Valentina Cirello, Michela Perrino, Simone De Leo, Elisa Magnani,
Elisa Pignatti, Beatrice Vigo, Manuela Simoni, Gaetano Bulfamante, Leonardo Vicentini, and Laura Fugazzola
Molecular and Cellular Endocrinology
(2015)
399 :288
-
Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF
V600E Harboring Pediatric Papillary Thyroid Carcinomas
Semen Onder, Sule Ozturk Sari, Gulcin Yegen, Ismail Cem Sormaz, Ismail Yilmaz, Sukran Poyrazoglu, Yasemin Sanlı, Yasemin Giles
Senyurek, Yersu Kapran, and Ozgur Mete
Endocrine Pathology
(2016)
27 :153
-
Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus
Statement
Nishant Agrawal, Maria R. Evasovich, Emad Kandil, Salem I. Noureldine, Erin A. Felger, Ralph P. Tufano, Dennis H. Kraus, Lisa
A. Orloff, Raymon Grogan, Peter Angelos, Brendan C. Stack, Bryan McIver, and Gregory W. Randolph
Head & Neck
(2017)
39 :1269
-
TERTpromoter mutations in thyroid cancer: a report from a Middle Eastern population
Ebtesam Qasem, Avaniyapuram Kannan Murugan, Hindi Al-Hindi, Mingzhao Xing, Mai Almohanna, Meshael Alswailem, and Ali S Alzahrani
Endocrine-Related Cancer
(2015)
22 :901
-
TERTpromoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
Martyn Bullock, Yan Ren, Christine O'Neill, Anthony Gill, Adam Aniss, Mark Sywak, Stan Sidhu, Leigh Delbridge, Diana Learoyd,
Florent de Vathaire, Bruce G. Robinson, and Roderick J. Clifton-Bligh
Clinical Endocrinology
(2016)
85 :283
-
Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis
De-tao Yin, Kun Yu, Run-qing Lu, Xianghua Li, Jianhui Xu, Mengyuan Lei, Hongqiang Li, Yongfei Wang, and Zhen Liu
Clinical Endocrinology
(2016)
85 :299
-
TERTpromoter mutations predict worse survival in laryngeal cancer patients
Yiping Qu, Siwen Dang, Kexia Wu, Yuan Shao, Qi Yang, Meiju Ji, Bingyin Shi, and Peng Hou
International Journal of Cancer
(2014)
135 :1008
-
Absence ofTERTpromoter mutations in primary melanocytic tumours of the central nervous system
Marco Gessi, Johannes van de Nes, Klaus Griewank, Valeria Barresi, Michael E. Buckland, Jutta Kirfel, Rosario Caltabiano,
Jennifer Hammes, Libero Lauriola, Torsten Pietsch, and Andreas Waha
Neuropathology and Applied Neurobiology
(2014)
40 :794
-
Role of hemithyroidectomy in differentiated thyroid cancer
Bianca Gibelli, Rosa Dionisio, and Mohssen Ansarin
Current Opinion in Otolaryngology & Head and Neck Surgery
(2015)
23 :99
-
High expression of metadherin correlates with malignant pathological features and poor prognostic significance in papillary
thyroid carcinoma
Wen-Fang Li, Gen Wang, Zong-Bin Zhao, and Chang-An Liu
Clinical Endocrinology
(2015)
83 :572
-
A six-genotype genetic prognostic model for papillary thyroid cancer
Xiaopei Shen, Rengyun Liu, and Mingzhao Xing
Endocrine-Related Cancer
(2017)
24 :41
-
A new POT1 germline mutation—expanding the spectrum of POT1-associated cancers
Tremika Le-Shan Wilson, Namita Hattangady, Antonio Marcondes Lerario, Carmen Williams, Erika Koeppe, Shane Quinonez, Jenae
Osborne, Kelly B. Cha, and Tobias Else
Familial Cancer
(2017)
16 :561
-
Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
Young Shin Song, Jung Ah Lim, and Young Joo Park
Endocrinology and Metabolism
(2015)
30 :252
-
Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
Mohammad A. Jafri, Shakeel A. Ansari, Mohammed H. Alqahtani, and Jerry W. Shay
Genome Medicine
(2016)
8 :
-
Telomerase in hematologic malignancies
Claudia Bruedigam and Steven W. Lane
Current Opinion in Hematology
(2016)
23 :346
